6.
Pairo-Castineira E, Clohisey S, Klaric L, Bretherick A, Rawlik K, Pasko D
. Genetic mechanisms of critical illness in COVID-19. Nature. 2020; 591(7848):92-98.
DOI: 10.1038/s41586-020-03065-y.
View
7.
Bischof E, Wolfe J, Klein S
. Clinical trials for COVID-19 should include sex as a variable. J Clin Invest. 2020; 130(7):3350-3352.
PMC: 7324163.
DOI: 10.1172/JCI139306.
View
8.
Sattar N, Ho F, Gill J, Ghouri N, Gray S, Celis-Morales C
. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank. Diabetes Metab Syndr. 2020; 14(5):1149-1151.
PMC: 7326434.
DOI: 10.1016/j.dsx.2020.06.060.
View
9.
Dudley J, Lee N
. Disparities in Age-specific Morbidity and Mortality From SARS-CoV-2 in China and the Republic of Korea. Clin Infect Dis. 2020; 71(15):863-865.
PMC: 7184419.
DOI: 10.1093/cid/ciaa354.
View
10.
Wang E, Mao T, Klein J, Dai Y, Huck J, Jaycox J
. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021; 595(7866):283-288.
DOI: 10.1038/s41586-021-03631-y.
View
11.
Zhang J, Wang X, Jia X, Li J, Hu K, Chen G
. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6):767-772.
PMC: 7159868.
DOI: 10.1016/j.cmi.2020.04.012.
View
12.
Cron R, Caricchio R, Chatham W
. Calming the cytokine storm in COVID-19. Nat Med. 2021; 27(10):1674-1675.
DOI: 10.1038/s41591-021-01500-9.
View
13.
Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W
. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021; 591(7848):124-130.
PMC: 8567458.
DOI: 10.1038/s41586-021-03234-7.
View
14.
Bost P, De Sanctis F, Cane S, Ugel S, Donadello K, Castellucci M
. Deciphering the state of immune silence in fatal COVID-19 patients. Nat Commun. 2021; 12(1):1428.
PMC: 7935849.
DOI: 10.1038/s41467-021-21702-6.
View
15.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z
. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062.
PMC: 7270627.
DOI: 10.1016/S0140-6736(20)30566-3.
View
16.
Hilmer S, Petrovic M, Le Couteur D, Schwartz J, Thuermann P
. Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond. Br J Clin Pharmacol. 2021; 87(9):3459-3461.
PMC: 8444940.
DOI: 10.1111/bcp.14967.
View
17.
Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L
. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ Res. 2020; .
PMC: 7641188.
DOI: 10.1161/CIRCRESAHA.120.317703.
View
18.
Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R
. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell. 2021; 184(19):4953-4968.e16.
PMC: 8373821.
DOI: 10.1016/j.cell.2021.08.016.
View
19.
Zhou Y, Xie Y, Tang L, Pu D, Zhu Y, Liu J
. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther. 2021; 6(1):317.
PMC: 8390046.
DOI: 10.1038/s41392-021-00733-x.
View
20.
Ren X, Wen W, Fan X, Hou W, Su B, Cai P
. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021; 184(7):1895-1913.e19.
PMC: 7857060.
DOI: 10.1016/j.cell.2021.01.053.
View